Page last updated: 2024-11-02

oxybutynin and Peripheral Arterial Disease

oxybutynin has been researched along with Peripheral Arterial Disease in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research Excerpts

ExcerptRelevanceReference
"A large proportion of vascular patients who received 2 weeks of nicotine replacement with or without the addition of brief smoking cessation counseling delivered by a vascular surgery provider were able to reduce smoking and maintain reduction after 6 months."5.30A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease. ( Holder, T; Indes, JE; Muhs, B; Ochoa Chaar, CI; Rajaee, S; Sarac, T; Sumpio, B; Toll, BA, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajaee, S1
Holder, T1
Indes, JE1
Muhs, B1
Sarac, T1
Sumpio, B1
Toll, BA1
Ochoa Chaar, CI1

Trials

1 trial available for oxybutynin and Peripheral Arterial Disease

ArticleYear
A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease.
    Annals of vascular surgery, 2019, Volume: 61

    Topics: Aneurysm; Cardiovascular Agents; Cholinergic Agents; Connecticut; Endovascular Procedures; Female; H

2019